Intervention Protocol

You have free access to this content

Bisphosphonates for osteoarthritis

  1. Wei Yang1,
  2. Qi Zhuo2,
  3. Wei Chai2,
  4. Jiying Chen2,
  5. Cheng Sun3,
  6. Yan Wang2,*

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 3 NOV 2013

DOI: 10.1002/14651858.CD010805


How to Cite

Yang W, Zhuo Q, Chai W, Chen J, Sun C, Wang Y. Bisphosphonates for osteoarthritis (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010805. DOI: 10.1002/14651858.CD010805.

Author Information

  1. 1

    Chinese PLA General Hospital, Department of Endocrinology, Beijing, Beijing, China

  2. 2

    Chinese PLA General Hospital, Department of Orthopaedic Surgery, Beijing, China

  3. 3

    Peking University Third Hospital, Department of Orthopaedic Surgery, Beijing, China

*Yan Wang, Department of Orthopaedic Surgery, Chinese PLA General Hospital, 28 Fuxing Road, Haidian district, Beijing, 100853, China. yannwang301@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 3 NOV 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the benefits and harms of bisphosphonates for the pharmacological treatment of the hip, knee and hand OA. Both symptomatic and structural outcomes will be evaluated.